【先声药业抗失眠创新药盐酸达利雷生片在中国获批上市】先声药业宣布,该公司与瑞士证券交易所上市公司Idorsia合作的抗失眠药科唯可®(通用名:盐酸达利雷生片),于近日获得国家药品监督管理局批准上市,用于治疗以入睡困难和/或睡眠维持困难为特征的成人失眠患者,且未被作为精神药品管制。

金融界
23 Jun
先声药业宣布,该公司与瑞士证券交易所上市公司Idorsia合作的抗失眠药科唯可®(通用名:盐酸达利雷生片),于近日获得国家药品监督管理局批准上市,用于治疗以入睡困难和/或睡眠维持困难为特征的成人失眠患者,且未被作为精神药品管制。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10